Testing effectiveness (Phase 2)Looking for participantsNCT06424340What this trial is testingMB-dNPM1-TCR.1 in Relapsed/Refractory AMLWho this might be right forLeukemia, Myeloid, Acute Miltenyi Biomedicine GmbH 29
Early research (Phase 1)Looking for participantsNCT06820268What this trial is testingXS-04 in Patients With Relapsed or Refractory Hematologic MalignanciesWho this might be right forB-cell LymphomaAcute Myeloid LeukemiaMyelodysplastic Syndrome Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 168
Early research (Phase 1)Study completedNCT00981240What this trial is testingDose Escalation, Safety and Pharmacokinetic Study of SAR103168 in Patients Refractory/ Relapsed Acute Leukemias or High-risk Myelodysplastic SyndromesWho this might be right forAcute Myelogenous Leukemia Sanofi 30
Early research (Phase 1)Ended earlyNCT04951778What this trial is testingStudy to Evaluate Safety and Tolerability of CC-91633 (BMS-986397) in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-Risk Myelodysplastic SyndromesWho this might be right forLeukemia, Myeloid, AcuteMyelodysplastic Syndromes Celgene 56
Testing effectiveness (Phase 2)Ended earlyNCT00871689What this trial is testingChemotherapy, Total-Body Irradiation, Donor Natural Killer Cell Infusion, Aldesleukin, and UCB Transplant in Treating Patients With Relapsed or Refractory AMLWho this might be right forLeukemia Masonic Cancer Center, University of Minnesota 2
Early research (Phase 1)Study completedNCT00045006What this trial is testingSuberoylanilide Hydroxamic Acid in Treating Patients With Advanced CancerWho this might be right forCancer Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)UnknownNCT01520558What this trial is testingCNDO-109-AANK for AML in First Complete Remission (CR1)Who this might be right forAcute Myeloid Leukemia Coronado Biosciences, Inc. 12
Early research (Phase 1)Active Not RecruitingNCT06325748What this trial is testingSENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDSWho this might be right forAML/MDSCD33 Expressing Hematological MalignanciesFLT3 Expressing Hematological Malignancies Senti Biosciences 21
Not applicableLooking for participantsNCT06452732What this trial is testingUsing Multiparametric Flow Cytometry to Detect Peripheral Blood and Bone Marrow Leukaemia Stem Cells for Relapse Prediction in P-AMLWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia Peking University People's Hospital 283
Early research (Phase 1)Study completedNCT00003693What this trial is testingDolastatin 10 in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous LeukemiaWho this might be right forLeukemiaMyelodysplastic Syndromes M.D. Anderson Cancer Center 30
Early research (Phase 1)Study completedNCT03441048What this trial is testingLintuzumab-Ac225 in Combination with Cladribine + Cytarabine + Filgastrim + Mitoxantrone (CLAG-M) for Relapsed/Refractory Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Medical College of Wisconsin 26
Testing effectiveness (Phase 2)Study completedNCT00011934What this trial is testingBone Marrow Transplantation Plus Biological Therapy in Treating Patients With Chronic Myeloid LeukemiaWho this might be right forLeukemia Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Study completedNCT02756572What this trial is testingEarly Allogeneic Hematopoietic Cell Transplantation in Treating Patients With Relapsed or Refractory High-Grade Myeloid NeoplasmsWho this might be right forBlasts 10 Percent or More of Bone Marrow Nucleated CellsChronic Myelomonocytic Leukemia-2High Grade Malignant Neoplasm+6 more University of Washington 30
Testing effectiveness (Phase 2)UnknownNCT04669067What this trial is testingTL-895 and KRT-232 Study in Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Telios Pharma, Inc. 18
Not applicableEnded earlyNCT00290628What this trial is testingDonor Umbilical Cord Blood Transplant in Treating Patients With Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersDiamond-blackfan AnemiaFanconi Anemia+6 more Masonic Cancer Center, University of Minnesota 43
Large-scale testing (Phase 3)Study completedNCT01305200What this trial is testingSupersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell TransplantWho this might be right forChildhood Acute Lymphoblastic Leukemia in RemissionChildhood Acute Myeloid Leukemia in RemissionChildhood Chronic Myelogenous Leukemia+24 more Children's Oncology Group 226
Testing effectiveness (Phase 2)Ended earlyNCT00023881What this trial is testingBortezomib in Treating Patients With Chronic Myelogenous LeukemiaWho this might be right forLeukemia M.D. Anderson Cancer Center 7
Large-scale testing (Phase 3)Study completedNCT00719563What this trial is testingAmerican Ginseng in Treating Patients With Fatigue Caused by CancerWho this might be right forChronic Myeloproliferative DisordersFatigueLeukemia+7 more Alliance for Clinical Trials in Oncology 364
Large-scale testing (Phase 3)Ended earlyNCT03616470What this trial is testingStudy to Determine the Efficacy of Uproleselan (GMI-1271) in Combination With Chemotherapy to Treat Relapsed/Refractory Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia GlycoMimetics Incorporated 388
Early research (Phase 1)Study completedNCT00104923What this trial is testingFenretinide in Treating Patients With Refractory or Relapsed Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+1 more California Cancer Consortium 29